Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
29 participants
INTERVENTIONAL
2016-07-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Burst Spinal Cord Stimulation for Neuropathic Pain
NCT01486108
BurstDR™ micrOdosing stimuLation in De-novo Patients
NCT03350256
Burst Spinal Cord Stimulation for Neuropathic Pain.
NCT03733886
Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy
NCT07250828
Long-term Effect of Motor Cortex Stimulation in Patients Suffering From Chronic Neuropathic Pain
NCT03189823
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects will be randomized 1:1:1 to one of the three groups. Each group will evaluate all 3 stimulation paradigms in different order.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stimulation order 1
Stimulations delivered in following order:
1. Standard burst
2. Burst Microdosing 1
3. Burst Microdosing 2
Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal pulse generator) parameters according to study protocol
Stimulation parameters are reprogrammed from original values to study defined ones
Stimulation order 2
Stimulations delivered in following order:
1. Burst Microdosing 1
2. Burst Microdosing 2
3. Standard burst
Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal pulse generator) parameters according to study protocol
Stimulation parameters are reprogrammed from original values to study defined ones
Stimulation order 3
Stimulations delivered in following order:
1. Burst Microdosing 2
2. Standard burst
3. Burst Microdosing 1
Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal pulse generator) parameters according to study protocol
Stimulation parameters are reprogrammed from original values to study defined ones
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal pulse generator) parameters according to study protocol
Stimulation parameters are reprogrammed from original values to study defined ones
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject has been exclusively using burst stimulation for at least three months;
* Subject is 18 years of age or older;
* Subject's pain-related medication regimen was stable in the 4 weeks prior to the screening evaluation;
* Subject agrees not to add or increase pain-related medication from enrollment through the study duration;
* Subject is willing to cooperate with the study requirements including compliance with the regimen and completion of all office visits;
Exclusion Criteria
* Subject is currently receiving, applying or considering seeking workers compensation, or is involved in disability litigation;
* Subject has a non SJM neuromodulation device
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medizinische Einrichtungen der Universität Düsseldorf
UNKNOWN
Klinikum Duisburg GmbH
UNKNOWN
NKO Sint-Augustinus Antwerpen
UNKNOWN
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lalit Venkatesan, Ph.D.
Role: STUDY_DIRECTOR
Abbott Medical Devices
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NKO Sint-Augustinus
Antwerp, , Belgium
Klinikum Duisburg GmbH
Duisburg, North Rhine-Westphalia, Germany
Medizinische Einrichtungen der Universität Düsseldorf
Düsseldorf, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SJM-CIP-10125
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.